Advertisement

Topics

TEVA Pharmaceuticals-Aktie: Risiken haben abgenommen! - Aktienanalyse

09:04 EDT 19 Jun 2017 | FinanzNachrichten

New York - TEVA Pharmaceuticals-Aktienanalyse der Analystin Irina Koffler von Mizuho Securities USA: Laut einer Aktienanalyse vertritt Irina Koffler, Aktienanalystin bei Mizuho Securities USA, in B...

Original Article: TEVA Pharmaceuticals-Aktie: Risiken haben abgenommen! - Aktienanalyse

NEXT ARTICLE

More From BioPortfolio on "TEVA Pharmaceuticals-Aktie: Risiken haben abgenommen! - Aktienanalyse"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...